These observations indicated that the KITENIN/ErbB4-c-Jun axis confers resistance to cetuximab in CRC cells, in which the KITENIN axis functions as an unconventional EGFR-independent signal pathway for EGF. Here, VANGL1 is linked to colorectal carcinoma.